The Biologic Revolution: How Oncology Biologics Are Reshaping Non-Hodgkin Lymphoma Care
Oncology biologics have revolutionized the treatment of non-Hodgkin lymphoma, offering targeted and highly effective therapies that have significantly improved patient outcomes. These complex, protein-based drugs, including monoclonal antibodies and antibody-drug conjugates, are designed to precisely target cancer cells, minimizing damage to healthy tissues and reducing side effects. According...
0 Comments 0 Shares 190 Views 0 Reviews